<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Laboratory Diagnosis of STIs - MOH Saudi Arabia</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            background: #f0f4f8;
            color: #1e293b;
            overflow: hidden;
        }

        .presentation-container {
            width: 100vw;
            height: 100vh;
            max-width: 1920px;
            max-height: 1080px;
            margin: 0 auto;
            position: relative;
            background: white;
        }

        .slide {
            display: none;
            width: 100%;
            height: 100%;
            position: relative;
            padding: 40px 60px 100px 60px;
            overflow: hidden;
            animation: fadeIn 0.5s ease-in-out;
        }

        .slide.active {
            display: block;
        }

        @keyframes fadeIn {
            from { opacity: 0; transform: translateY(20px); }
            to { opacity: 1; transform: translateY(0); }
        }

        /* Floating header box */
        .slide-header-box {
            position: absolute;
            top: 40px;
            right: 60px;
            background: linear-gradient(135deg, #3b82f6 0%, #2563eb 100%);
            color: white;
            padding: 15px 25px;
            border-radius: 12px;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.15);
            z-index: 10;
            min-width: 280px;
            max-width: 380px;
        }

        /* For image slides - no slide number */
        .slide-header-box.image-header {
            padding: 12px 20px;
        }

        .slide-number {
            font-size: 13px;
            opacity: 0.9;
            margin-bottom: 6px;
            font-weight: 500;
        }

        .slide-header-box h1,
        .slide-header-box h2 {
            font-size: 20px;
            font-weight: 700;
            line-height: 1.2;
            margin: 0;
            color: white;
        }

        /* Smart content layouts */
        .content {
            height: calc(100% - 60px);
            overflow-y: auto;
            overflow-x: hidden;
        }

        /* Left column content that avoids header */
        .left-content {
            float: left;
            width: calc(100% - 420px);
            margin-bottom: 20px;
        }

        /* Right content that fits beside header */
        .right-space {
            float: right;
            width: 400px;
            padding-top: 80px;
        }

        /* Full width content below */
        .full-width-content {
            clear: both;
            width: 100%;
        }

        /* Special content layouts */
        .title-content {
            display: flex;
            flex-direction: column;
            justify-content: center;
            align-items: center;
            height: 100%;
            text-align: center;
        }

        .image-content {
            display: flex;
            align-items: center;
            justify-content: center;
            height: 100%;
        }

        .image-content img {
            max-width: 90%;
            max-height: 90%;
            object-fit: contain;
        }

        /* Grid layouts */
        .two-columns {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 40px;
        }

        .three-columns {
            display: grid;
            grid-template-columns: 1fr 1fr 1fr;
            gap: 30px;
        }

        /* Typography */
        h1 {
            font-size: 42px;
            font-weight: 800;
            color: #1e293b;
            margin-bottom: 20px;
            line-height: 1.1;
        }

        h2 {
            font-size: 28px;
            font-weight: 700;
            color: #334155;
            margin-bottom: 16px;
            line-height: 1.2;
        }

        h3 {
            font-size: 20px;
            font-weight: 600;
            color: #dc2626;
            margin-top: 20px;
            margin-bottom: 12px;
        }

        h4 {
            font-size: 18px;
            font-weight: 600;
            color: #3b82f6;
            margin-top: 16px;
            margin-bottom: 10px;
        }

        p {
            font-size: 16px;
            line-height: 1.6;
            color: #475569;
            margin-bottom: 12px;
        }

        ul, ol {
            font-size: 16px;
            line-height: 1.6;
            color: #475569;
            margin-bottom: 16px;
            padding-left: 20px;
        }

        li {
            margin-bottom: 8px;
        }

        /* Compact text for dense slides */
        .compact {
            font-size: 15px;
            line-height: 1.5;
        }

        .compact ul, .compact ol {
            font-size: 15px;
            line-height: 1.5;
        }

        .compact li {
            margin-bottom: 6px;
        }

        /* Tables */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 16px 0;
            font-size: 14px;
            background: white;
            box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
        }

        th {
            background-color: #e0e7ff;
            color: #3730a3;
            padding: 10px 12px;
            text-align: left;
            font-weight: 600;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        td {
            padding: 10px 12px;
            border-bottom: 1px solid #e5e7eb;
            font-size: 14px;
        }

        tr:last-child td {
            border-bottom: none;
        }

        tr:hover {
            background-color: #f9fafb;
        }

        /* Small tables */
        table.small {
            font-size: 13px;
        }

        table.small th {
            padding: 8px 10px;
            font-size: 12px;
        }

        table.small td {
            padding: 8px 10px;
            font-size: 13px;
        }

        /* Key points box */
        .key-point {
            background: linear-gradient(135deg, #fef3c7 0%, #fde68a 100%);
            border-left: 4px solid #f59e0b;
            padding: 16px;
            margin: 16px 0;
            border-radius: 8px;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.05);
        }

        .key-point strong {
            color: #d97706;
            display: block;
            margin-bottom: 6px;
            font-size: 14px;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* Warning box */
        .warning {
            background: linear-gradient(135deg, #fee2e2 0%, #fecaca 100%);
            border-left: 4px solid #dc2626;
            padding: 16px;
            margin: 16px 0;
            border-radius: 8px;
        }

        .warning strong {
            color: #dc2626;
            display: block;
            margin-bottom: 6px;
        }

        /* Navigation */
        .navigation {
            position: absolute;
            bottom: 0;
            left: 0;
            right: 0;
            height: 60px;
            background: #1e293b;
            display: flex;
            align-items: center;
            justify-content: space-between;
            padding: 0 40px;
            color: white;
            z-index: 20;
        }

        .nav-button {
            background: #3b82f6;
            color: white;
            border: none;
            padding: 8px 24px;
            border-radius: 6px;
            font-size: 16px;
            font-weight: 500;
            cursor: pointer;
            transition: all 0.2s;
        }

        .nav-button:hover {
            background: #2563eb;
            transform: translateY(-1px);
        }

        .nav-button:disabled {
            background: #64748b;
            cursor: not-allowed;
            transform: none;
        }

        .slide-counter {
            font-size: 16px;
            font-weight: 500;
        }

        /* Loading screen */
        .loading {
            position: fixed;
            top: 0;
            left: 0;
            right: 0;
            bottom: 0;
            background: white;
            display: flex;
            align-items: center;
            justify-content: center;
            z-index: 9999;
        }

        /* Responsive adjustments */
        @media (max-width: 1200px) {
            .slide {
                padding: 30px 40px 90px 40px;
            }
            .left-content {
                width: calc(100% - 380px);
            }
            .two-columns {
                gap: 30px;
            }
        }

        @media (max-width: 900px) {
            .slide-header-box {
                position: static;
                margin-bottom: 20px;
                max-width: 100%;
            }
            .left-content {
                float: none;
                width: 100%;
            }
            .two-columns,
            .three-columns {
                grid-template-columns: 1fr;
            }
        }

        /* Print styles */
        @media print {
            .navigation {
                display: none;
            }
            .slide {
                page-break-after: always;
                height: auto;
                padding-bottom: 40px;
            }
            .content {
                overflow: visible;
                height: auto;
            }
        }

        @keyframes spin {
            to { transform: rotate(360deg); }
        }
    </style>
</head>
<body>
    <div class="loading" id="loading">
        <div style="text-align: center;">
            <h2 style="color: #3b82f6; margin-bottom: 20px;">Loading Presentation...</h2>
            <div style="width: 50px; height: 50px; border: 4px solid #e5e7eb; border-top-color: #3b82f6; border-radius: 50%; animation: spin 1s linear infinite; margin: 0 auto;"></div>
        </div>
    </div>

    <div class="presentation-container">
        <!-- Slide 1: Title Slide -->
        <div class="slide active">
            <div class="title-content">
                <h1 style="color: #1e293b; font-size: 48px; margin-bottom: 28px;">Laboratory Diagnosis of<br>Sexually Transmitted Infections</h1>
                <p style="font-size: 22px; color: #64748b; margin-bottom: 40px;">Comprehensive Guide for Healthcare Professionals</p>
                <div style="display: flex; gap: 40px; align-items: center; justify-content: center;">
                    <img src="https://via.placeholder.com/120x120/3b82f6/ffffff?text=MOH" alt="MOH Logo" style="height: 120px;">
                    <div style="text-align: left;">
                        <p style="font-size: 18px; color: #475569; margin-bottom: 8px;"><strong>Ministry of Health - Saudi Arabia</strong></p>
                        <p style="font-size: 16px; color: #64748b;">STI Control Program</p>
                        <p style="font-size: 14px; color: #94a3b8; margin-top: 8px;">2024 Training Module</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 2: Objectives -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 2 of 45</div>
                <h2>Learning Objectives</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>By the end of this session, participants will be able to:</h3>
                    <ol style="font-size: 18px; line-height: 1.8;">
                        <li>Understand the principles of STI laboratory diagnosis</li>
                        <li>Select appropriate tests for different clinical scenarios</li>
                        <li>Interpret laboratory results accurately</li>
                        <li>Apply quality assurance principles in STI testing</li>
                        <li>Recognize limitations of different diagnostic methods</li>
                        <li>Implement Saudi national guidelines for STI testing</li>
                    </ol>
                </div>
                <div class="full-width-content">
                    <div class="key-point" style="margin-top: 30px;">
                        <strong>Duration:</strong>
                        <p>This comprehensive module is designed for 60 minutes of instruction with interactive discussions</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 3: Agenda -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 3 of 45</div>
                <h2>Session Agenda</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <table>
                        <tr>
                            <th style="width: 30%;">Time</th>
                            <th>Topic</th>
                        </tr>
                        <tr>
                            <td>5 minutes</td>
                            <td>Introduction & Importance</td>
                        </tr>
                        <tr>
                            <td>10 minutes</td>
                            <td>General Principles & Specimen Collection</td>
                        </tr>
                        <tr>
                            <td>25 minutes</td>
                            <td>Pathogen-Specific Diagnosis</td>
                        </tr>
                        <tr>
                            <td>10 minutes</td>
                            <td>Point-of-Care & Multiplex Testing</td>
                        </tr>
                        <tr>
                            <td>5 minutes</td>
                            <td>Saudi Guidelines & Future Directions</td>
                        </tr>
                        <tr>
                            <td>5 minutes</td>
                            <td>Q&A and Discussion</td>
                        </tr>
                    </table>
                </div>
            </div>
        </div>

        <!-- Slide 4: Introduction -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 4 of 45</div>
                <h2>Why Accurate Laboratory Diagnosis Matters</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>The Critical Role of Laboratory Testing</h3>
                    <ul>
                        <li>STIs are a major public health concern globally and in Saudi Arabia</li>
                        <li>Many STIs are <strong>asymptomatic</strong> - laboratory testing is crucial</li>
                        <li>Accurate diagnosis enables:
                            <ul>
                                <li>Appropriate treatment selection</li>
                                <li>Prevention of complications</li>
                                <li>Partner notification and treatment</li>
                                <li>Surveillance and public health planning</li>
                            </ul>
                        </li>
                    </ul>
                </div>
                <div class="full-width-content">
                    <div class="two-columns">
                        <div class="key-point">
                            <strong>Key Statistics:</strong>
                            <p>Up to 80% of chlamydia and gonorrhea infections in women are asymptomatic</p>
                        </div>
                        <div class="warning">
                            <strong>Remember:</strong>
                            <p>Clinical diagnosis alone is unreliable for most STIs - laboratory confirmation is essential</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 5: Types of Diagnostic Tests -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 5 of 45</div>
                <h2>Types of Diagnostic Tests</h2>
            </div>
            <div class="content">
                <h3>Three Main Categories</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Test Type</th>
                            <th>Examples</th>
                            <th>Characteristics</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Direct Detection</strong></td>
                            <td>
                                • Microscopy<br>
                                • Antigen detection<br>
                                • Nucleic acid tests
                            </td>
                            <td>
                                • Detects organism/components<br>
                                • High specificity<br>
                                • Variable sensitivity
                            </td>
                        </tr>
                        <tr>
                            <td><strong>Culture</strong></td>
                            <td>
                                • Bacterial culture<br>
                                • Viral culture<br>
                                • Cell culture
                            </td>
                            <td>
                                • 100% specificity<br>
                                • Allows susceptibility testing<br>
                                • Lower sensitivity
                            </td>
                        </tr>
                        <tr>
                            <td><strong>Serological</strong></td>
                            <td>
                                • Antibody detection<br>
                                • Antigen detection<br>
                                • Combined Ag/Ab
                            </td>
                            <td>
                                • Good for screening<br>
                                • Window period limitation<br>
                                • May need confirmation
                            </td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <!-- Slide 6: Specimen Collection -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 6 of 45</div>
                <h2>Specimen Collection: Critical First Step</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Types of Specimens</h3>
                    <ul>
                        <li><strong>Urogenital:</strong> Urine, urethral, cervical, vaginal swabs</li>
                        <li><strong>Extragenital:</strong> Pharyngeal, rectal swabs</li>
                        <li><strong>Blood:</strong> Serum, plasma, whole blood</li>
                        <li><strong>Lesions:</strong> Ulcer swabs, vesicle fluid</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div class="warning">
                            <strong>Critical:</strong>
                            <p>Improper specimen collection is the most common cause of false-negative results</p>
                        </div>
                        
                        <div>
                            <h3>Key Collection Principles</h3>
                            <table class="small">
                                <tr>
                                    <th>Specimen</th>
                                    <th>Key Points</th>
                                </tr>
                                <tr>
                                    <td>First-void urine</td>
                                    <td>First 10-20 mL, no urination for ≥1 hour</td>
                                </tr>
                                <tr>
                                    <td>Vaginal swab</td>
                                    <td>Self-collected or clinician, preferred for NAAT</td>
                                </tr>
                                <tr>
                                    <td>Cervical swab</td>
                                    <td>Remove excess mucus first, rotate 360°</td>
                                </tr>
                                <tr>
                                    <td>Ulcer specimen</td>
                                    <td>Clean with saline, sample base of ulcer</td>
                                </tr>
                            </table>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 7: Transport and Storage -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 7 of 45</div>
                <h2>Specimen Transport and Storage</h2>
            </div>
            <div class="content">
                <h3>Transport Requirements</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Specimen Type</th>
                            <th>Transport Medium</th>
                            <th>Temperature</th>
                            <th>Maximum Time</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>NAAT swabs</td>
                            <td>Manufacturer's medium</td>
                            <td>2-8°C</td>
                            <td>7 days</td>
                        </tr>
                        <tr>
                            <td>Culture swabs</td>
                            <td>Stuart's/Amies</td>
                            <td>Room temp</td>
                            <td>24 hours</td>
                        </tr>
                        <tr>
                            <td>Gonococcal culture</td>
                            <td>Direct plating/CO₂</td>
                            <td>35-37°C</td>
                            <td>Immediate</td>
                        </tr>
                        <tr>
                            <td>Serum</td>
                            <td>None</td>
                            <td>2-8°C</td>
                            <td>7 days</td>
                        </tr>
                        <tr>
                            <td>HSV swab</td>
                            <td>Viral transport</td>
                            <td>4°C</td>
                            <td>48 hours</td>
                        </tr>
                    </tbody>
                </table>

                <div class="key-point" style="margin-top: 20px;">
                    <strong>Best Practice:</strong>
                    <p>Label specimens immediately at bedside with 2 identifiers. Never pre-label collection containers.</p>
                </div>
            </div>
        </div>

        <!-- Slide 8: Quality Management -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 8 of 45</div>
                <h2>Laboratory Quality Management</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Three Phases of Quality</h3>
                    
                    <h4 style="color: #3b82f6;">Pre-analytical (70% of errors)</h4>
                    <ul class="compact">
                        <li>Proper patient identification</li>
                        <li>Correct specimen collection</li>
                        <li>Appropriate transport conditions</li>
                        <li>Complete requisition forms</li>
                    </ul>
                </div>

                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h4 style="color: #3b82f6;">Analytical (10% of errors)</h4>
                            <ul class="compact">
                                <li>Daily quality control</li>
                                <li>Equipment calibration</li>
                                <li>Standard operating procedures</li>
                                <li>Staff competency</li>
                            </ul>
                        </div>
                        <div>
                            <h4 style="color: #3b82f6;">Post-analytical (20% of errors)</h4>
                            <ul class="compact">
                                <li>Result verification</li>
                                <li>Timely reporting</li>
                                <li>Clear interpretation</li>
                                <li>Critical value notification</li>
                            </ul>
                        </div>
                    </div>
                    
                    <div class="key-point" style="margin-top: 20px;">
                        <strong>Quality Indicators:</strong>
                        <p>Monitor specimen rejection rate (<2%), turnaround time, and critical value reporting time</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 9: Internal Quality Control -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 9 of 45</div>
                <h2>Internal Quality Control</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Essential Elements</h3>
                    <table class="small">
                        <tr>
                            <th>Component</th>
                            <th>Frequency</th>
                            <th>Action</th>
                        </tr>
                        <tr>
                            <td>Positive/Negative Controls</td>
                            <td>Each run</td>
                            <td>Document results</td>
                        </tr>
                        <tr>
                            <td>Temperature monitoring</td>
                            <td>Daily</td>
                            <td>Record, alert if out</td>
                        </tr>
                        <tr>
                            <td>Reagent checks</td>
                            <td>Before use</td>
                            <td>Check expiry</td>
                        </tr>
                        <tr>
                            <td>Equipment maintenance</td>
                            <td>Per schedule</td>
                            <td>Preventive care</td>
                        </tr>
                    </table>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Westgard Rules</h3>
                            <ul>
                                <li><strong>1-3s:</strong> Warning - one control exceeds 3 SD</li>
                                <li><strong>2-2s:</strong> Reject - two consecutive controls exceed 2 SD</li>
                                <li><strong>R-4s:</strong> Reject - range between controls exceeds 4 SD</li>
                            </ul>
                        </div>
                        <div class="warning">
                            <strong>Never report patient results if QC fails!</strong>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 10: External Quality Assessment -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 10 of 45</div>
                <h2>External Quality Assessment</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Proficiency Testing Programs</h3>
                    <ul>
                        <li>Mandatory participation for accredited laboratories</li>
                        <li>Blind samples sent periodically</li>
                        <li>Compare performance with peer laboratories</li>
                        <li>Identify systematic errors</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Available Programs</h3>
                            <table class="small">
                                <tr>
                                    <th>Provider</th>
                                    <th>Coverage</th>
                                </tr>
                                <tr>
                                    <td>CAP</td>
                                    <td>Comprehensive STI panel</td>
                                </tr>
                                <tr>
                                    <td>UK NEQAS</td>
                                    <td>Microbiology and serology</td>
                                </tr>
                                <tr>
                                    <td>WHO EQAS</td>
                                    <td>HIV, syphilis</td>
                                </tr>
                                <tr>
                                    <td>Regional</td>
                                    <td>Country-specific</td>
                                </tr>
                            </table>
                        </div>
                        <div class="key-point">
                            <strong>Action on EQA Failures:</strong>
                            <p>Investigate immediately, implement corrective actions, verify with retesting, document all steps</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 11: Syphilis Overview -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 11 of 45</div>
                <h2>Syphilis: Treponema pallidum</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Key Characteristics</h3>
                    <ul>
                        <li>Spirochete bacterium - cannot be cultured routinely</li>
                        <li>Transmission: Sexual contact, vertical, blood</li>
                        <li>Clinical stages: Primary, secondary, latent, tertiary</li>
                        <li>Great imitator - diverse clinical manifestations</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <h3>Clinical Stages and Testing</h3>
                    <table>
                        <tr>
                            <th>Stage</th>
                            <th>Time</th>
                            <th>Clinical Features</th>
                            <th>Tests</th>
                        </tr>
                        <tr>
                            <td>Primary</td>
                            <td>3-90 days</td>
                            <td>Painless chancre</td>
                            <td>Direct detection + Serology</td>
                        </tr>
                        <tr>
                            <td>Secondary</td>
                            <td>4-10 weeks</td>
                            <td>Rash, systemic</td>
                            <td>Serology (high titers)</td>
                        </tr>
                        <tr>
                            <td>Latent</td>
                            <td>Variable</td>
                            <td>Asymptomatic</td>
                            <td>Serology only</td>
                        </tr>
                        <tr>
                            <td>Tertiary</td>
                            <td>Years</td>
                            <td>Gummas, CVS, neuro</td>
                            <td>Serology + CSF</td>
                        </tr>
                    </table>
                </div>
            </div>
        </div>

        <!-- Slide 12: Syphilis Direct Detection -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 12 of 45</div>
                <h2>Syphilis: Direct Detection Methods</h2>
            </div>
            <div class="content">
                <h3>Available Methods</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Method</th>
                            <th>Sensitivity</th>
                            <th>Specificity</th>
                            <th>Comments</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Darkfield Microscopy</strong></td>
                            <td>80%</td>
                            <td>97%</td>
                            <td>Requires expertise, immediate exam</td>
                        </tr>
                        <tr>
                            <td><strong>DFA-TP</strong></td>
                            <td>90%</td>
                            <td>99%</td>
                            <td>Not for oral lesions</td>
                        </tr>
                        <tr>
                            <td><strong>PCR</strong></td>
                            <td>95%</td>
                            <td>99%</td>
                            <td>Not widely available</td>
                        </tr>
                        <tr>
                            <td><strong>IHC</strong></td>
                            <td>70%</td>
                            <td>95%</td>
                            <td>For tissue specimens</td>
                        </tr>
                    </tbody>
                </table>

                <div class="two-columns" style="margin-top: 20px;">
                    <div>
                        <h3>Specimen Collection for Direct Detection</h3>
                        <ol class="compact">
                            <li>Clean lesion with saline (not antiseptic)</li>
                            <li>Abrade surface gently to induce serous exudate</li>
                            <li>Collect clear fluid (not blood or pus)</li>
                            <li>For darkfield: Examine immediately</li>
                            <li>For DFA/PCR: Use appropriate transport</li>
                        </ol>
                    </div>
                    <div class="warning">
                        <strong>Limitation:</strong>
                        <p>Direct detection only useful for active lesions in primary and secondary syphilis</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 13: Syphilis Serology Overview -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 13 of 45</div>
                <h2>Syphilis: Serological Tests</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Two Categories of Tests</h3>
                    
                    <div style="background: #eff6ff; padding: 16px; border-radius: 8px; margin-bottom: 16px;">
                        <h4 style="color: #1e40af;">Non-treponemal Tests</h4>
                        <ul class="compact">
                            <li>RPR (Rapid Plasma Reagin)</li>
                            <li>VDRL (Venereal Disease Research Lab)</li>
                            <li>Detect antibodies to cardiolipin</li>
                            <li>Quantitative (titer)</li>
                            <li>Monitor treatment response</li>
                        </ul>
                    </div>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div style="background: #f0fdf4; padding: 16px; border-radius: 8px;">
                            <h4 style="color: #166534;">Treponemal Tests</h4>
                            <ul class="compact">
                                <li>TPPA/TPHA</li>
                                <li>FTA-ABS</li>
                                <li>EIA/CIA</li>
                                <li>Immunoblots</li>
                                <li>Remain positive for life</li>
                            </ul>
                        </div>
                        
                        <div>
                            <h3>False Positive Causes</h3>
                            <table class="small">
                                <tr>
                                    <th>Non-treponemal</th>
                                    <th>Treponemal</th>
                                </tr>
                                <tr>
                                    <td>
                                        • Pregnancy<br>
                                        • Autoimmune<br>
                                        • Acute infections<br>
                                        • Elderly
                                    </td>
                                    <td>
                                        • Other treponemes<br>
                                        • Lyme disease<br>
                                        • Technical error
                                    </td>
                                </tr>
                            </table>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Example Image Slide -->
        <div class="slide">
            <div class="slide-header-box image-header">
                <h2>Syphilis Antibody Response Timeline</h2>
            </div>
            <div class="image-content">
                <img src="https://raw.githubusercontent.com/prof-bandar/moh-sti/refs/heads/main/1_syphillisA-01.png" 
                     alt="Graph showing treponemal and non-treponemal antibody responses over time">
            </div>
        </div>

        <!-- Slide 14: Syphilis Testing Algorithms -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 14 of 45</div>
                <h2>Syphilis Testing Algorithms</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Traditional Algorithm</h3>
                    <ol>
                        <li>Screen with non-treponemal test (RPR/VDRL)</li>
                        <li>If positive → Confirm with treponemal test (TPPA)</li>
                        <li>Report with titer (e.g., RPR 1:32, TPPA positive)</li>
                    </ol>

                    <h3 style="margin-top: 30px;">Reverse Algorithm</h3>
                    <ol>
                        <li>Screen with treponemal test (EIA/CIA)</li>
                        <li>If positive → Perform non-treponemal test (RPR)</li>
                        <li>If discordant → Second treponemal test (TPPA)</li>
                    </ol>
                </div>
                
                <div class="full-width-content">
                    <h3>Result Interpretation</h3>
                    <table>
                        <tr>
                            <th>Treponemal</th>
                            <th>Non-treponemal</th>
                            <th>Interpretation</th>
                        </tr>
                        <tr>
                            <td>Positive</td>
                            <td>Positive</td>
                            <td>Active syphilis (confirm stage)</td>
                        </tr>
                        <tr>
                            <td>Positive</td>
                            <td>Negative</td>
                            <td>Past treated syphilis OR early/late syphilis</td>
                        </tr>
                        <tr>
                            <td>Negative</td>
                            <td>Positive</td>
                            <td>False positive (confirm with another treponemal)</td>
                        </tr>
                    </table>
                </div>
            </div>
        </div>

        <!-- Slide 15: Syphilis Treatment Monitoring -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 15 of 45</div>
                <h2>Monitoring Syphilis Treatment</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Key Principles</h3>
                    <ul>
                        <li>Use <strong>quantitative non-treponemal tests</strong> (RPR/VDRL)</li>
                        <li>4-fold decline in titer = successful treatment</li>
                        <li>Treponemal tests remain positive - do NOT use for monitoring</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Follow-up Schedule</h3>
                            <table class="small">
                                <tr>
                                    <th>Stage</th>
                                    <th>Follow-up</th>
                                    <th>Expected</th>
                                </tr>
                                <tr>
                                    <td>Primary/Secondary</td>
                                    <td>6, 12 months</td>
                                    <td>4-fold by 6-12 mo</td>
                                </tr>
                                <tr>
                                    <td>Early Latent</td>
                                    <td>6, 12, 24 months</td>
                                    <td>4-fold by 12-24 mo</td>
                                </tr>
                                <tr>
                                    <td>Late Latent</td>
                                    <td>6, 12, 24 months</td>
                                    <td>May decline slowly</td>
                                </tr>
                                <tr>
                                    <td>Neurosyphilis</td>
                                    <td>Every 6 months</td>
                                    <td>CSF + serology</td>
                                </tr>
                            </table>
                        </div>
                        <div class="warning">
                            <strong>Treatment Failure:</strong>
                            <p>No 4-fold decline or clinical signs persist → Re-evaluate, consider neurosyphilis, retreat</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 16: Gonorrhea Overview -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 16 of 45</div>
                <h2>Gonorrhea: Neisseria gonorrhoeae</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Key Characteristics</h3>
                    <ul>
                        <li>Gram-negative intracellular diplococcus</li>
                        <li>Affects urogenital, pharyngeal, and rectal sites</li>
                        <li>Often asymptomatic, especially in women (>50%)</li>
                        <li>Can cause PID, infertility, disseminated infection</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Clinical Presentations</h3>
                            <table class="small">
                                <tr>
                                    <th>Site</th>
                                    <th>Symptoms</th>
                                    <th>Complications</th>
                                </tr>
                                <tr>
                                    <td>Male urethra</td>
                                    <td>Purulent discharge</td>
                                    <td>Epididymitis</td>
                                </tr>
                                <tr>
                                    <td>Female cervix</td>
                                    <td>Often asymptomatic</td>
                                    <td>PID, infertility</td>
                                </tr>
                                <tr>
                                    <td>Pharynx</td>
                                    <td>Usually asymptomatic</td>
                                    <td>Transmission</td>
                                </tr>
                                <tr>
                                    <td>Rectum</td>
                                    <td>Discharge, pain</td>
                                    <td>Proctitis</td>
                                </tr>
                            </table>
                        </div>
                        <div class="key-point">
                            <strong>Antimicrobial Resistance Crisis:</strong>
                            <p>Rising resistance to all first-line antibiotics - culture for susceptibility testing is critical</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 17: Gonorrhea Microscopy -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 17 of 45</div>
                <h2>Gonorrhea: Microscopy</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Gram Stain Method</h3>
                    <ol>
                        <li>Prepare smear from discharge/swab</li>
                        <li>Heat fix gently</li>
                        <li>Gram stain procedure</li>
                        <li>Look for intracellular Gram-negative diplococci in PMNs</li>
                    </ol>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Performance by Site</h3>
                            <table class="small">
                                <thead>
                                    <tr>
                                        <th>Site</th>
                                        <th>Sensitivity</th>
                                        <th>Specificity</th>
                                        <th>Use</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td>Male urethral</td>
                                        <td>95%</td>
                                        <td>99%</td>
                                        <td><strong>Recommended</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Cervical</td>
                                        <td>50%</td>
                                        <td>95%</td>
                                        <td>Limited value</td>
                                    </tr>
                                    <tr>
                                        <td>Pharyngeal</td>
                                        <td>&lt;20%</td>
                                        <td>Poor</td>
                                        <td><strong>Not recommended</strong></td>
                                    </tr>
                                    <tr>
                                        <td>Rectal</td>
                                        <td>40%</td>
                                        <td>Poor</td>
                                        <td><strong>Not recommended</strong></td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <div class="warning">
                            <strong>Important:</strong>
                            <p>Gram stain is only reliable for symptomatic male urethral discharge</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 18: Gonorrhea Culture -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 18 of 45</div>
                <h2>Gonorrhea: Culture Methods</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Culture Requirements</h3>
                    <ul>
                        <li><strong>Media:</strong> Chocolate agar, Thayer-Martin, MTM</li>
                        <li><strong>Atmosphere:</strong> 5-10% CO₂, humid</li>
                        <li><strong>Temperature:</strong> 35-37°C</li>
                        <li><strong>Transport:</strong> Immediate plating or CO₂ transport</li>
                    </ul>

                    <h3 style="margin-top: 20px;">Identification Steps</h3>
                    <ol class="compact">
                        <li>Gray, mucoid colonies on chocolate agar</li>
                        <li>Oxidase positive</li>
                        <li>Catalase positive</li>
                        <li>Gram-negative diplococci</li>
                        <li>Sugar utilization: Glucose only</li>
                    </ol>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div class="key-point">
                            <strong>Critical Advantage:</strong>
                            <p>Culture allows antimicrobial susceptibility testing - essential for resistance surveillance</p>
                        </div>
                        <div>
                            <h3>Limitations</h3>
                            <ul class="compact">
                                <li>Organism is fragile - dies quickly</li>
                                <li>Lower sensitivity than NAAT (70-85%)</li>
                                <li>Requires expertise and resources</li>
                                <li>Takes 24-72 hours</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 19: Gonorrhea NAAT -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 19 of 45</div>
                <h2>Gonorrhea: Nucleic Acid Testing</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>NAAT Advantages</h3>
                    <ul>
                        <li>Superior sensitivity (>95%) compared to culture</li>
                        <li>Can test multiple anatomical sites</li>
                        <li>Stable specimens - no viability required</li>
                        <li>Automated platforms available</li>
                        <li>Co-testing with <em>Chlamydia trachomatis</em></li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Specimen Types for NAAT</h3>
                            <table class="small">
                                <tr>
                                    <th>Patient</th>
                                    <th>Preferred</th>
                                    <th>Notes</th>
                                </tr>
                                <tr>
                                    <td>Males</td>
                                    <td>First-void urine</td>
                                    <td>First 10-20 mL</td>
                                </tr>
                                <tr>
                                    <td>Females</td>
                                    <td>Vaginal swab</td>
                                    <td>Self or clinician</td>
                                </tr>
                                <tr>
                                    <td>Extragenital</td>
                                    <td>Site swab</td>
                                    <td>Based on practices</td>
                                </tr>
                            </table>
                        </div>
                        <div class="warning">
                            <strong>Limitation:</strong>
                            <p>NAAT cannot provide antimicrobial susceptibility - culture still needed for resistance testing</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 20: Gonorrhea Resistance -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 20 of 45</div>
                <h2>Gonorrhea: Antimicrobial Resistance</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Global Resistance Crisis</h3>
                    <ul>
                        <li>Resistance to all first-line antibiotics has emerged</li>
                        <li>Penicillin, tetracycline, fluoroquinolones - widespread</li>
                        <li>Azithromycin resistance increasing</li>
                        <li>Ceftriaxone is last remaining empiric option</li>
                        <li>XDR (extensively drug-resistant) strains reported</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Susceptibility Testing Methods</h3>
                            <table class="small">
                                <tr>
                                    <th>Method</th>
                                    <th>Use</th>
                                    <th>Comments</th>
                                </tr>
                                <tr>
                                    <td>Disk Diffusion</td>
                                    <td>Routine</td>
                                    <td>CLSI guidelines</td>
                                </tr>
                                <tr>
                                    <td>E-test</td>
                                    <td>MIC</td>
                                    <td>More precise</td>
                                </tr>
                                <tr>
                                    <td>Agar Dilution</td>
                                    <td>Reference</td>
                                    <td>Gold standard</td>
                                </tr>
                            </table>
                        </div>
                        <div class="key-point">
                            <strong>Saudi Recommendation:</strong>
                            <p>Culture from treatment failures and perform susceptibility testing. Report to surveillance.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 21: Chlamydia Overview -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 21 of 45</div>
                <h2>Chlamydia trachomatis</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Key Characteristics</h3>
                    <ul>
                        <li>Obligate intracellular bacterium</li>
                        <li>Most common bacterial STI worldwide</li>
                        <li>70-80% asymptomatic in women, 50% in men</li>
                        <li>Major cause of PID, infertility, ectopic pregnancy</li>
                        <li>Includes LGV serovars (L1, L2, L3)</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <h3>Clinical Syndromes</h3>
                    <table>
                        <tr>
                            <th>Syndrome</th>
                            <th>Serovars</th>
                            <th>Features</th>
                        </tr>
                        <tr>
                            <td>Urogenital infection</td>
                            <td>D-K</td>
                            <td>Urethritis, cervicitis, PID</td>
                        </tr>
                        <tr>
                            <td>Lymphogranuloma venereum</td>
                            <td>L1, L2, L3</td>
                            <td>Genital ulcer, lymphadenopathy</td>
                        </tr>
                        <tr>
                            <td>Trachoma</td>
                            <td>A, B, C</td>
                            <td>Eye infection (not STI)</td>
                        </tr>
                        <tr>
                            <td>Neonatal</td>
                            <td>D-K</td>
                            <td>Conjunctivitis, pneumonia</td>
                        </tr>
                    </table>
                </div>
            </div>
        </div>

        <!-- Slide 22: Chlamydia Diagnosis -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 22 of 45</div>
                <h2>Chlamydia: Diagnostic Methods</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Evolution of Testing</h3>
                    <ul>
                        <li><strong>Historical:</strong> Cell culture (McCoy cells) - Complex</li>
                        <li><strong>Transitional:</strong> DFA, EIA - Lower sensitivity</li>
                        <li><strong>Current Standard:</strong> NAAT - Highly sensitive</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>NAAT Performance</h3>
                            <table>
                                <tr>
                                    <th>Parameter</th>
                                    <th>Value</th>
                                </tr>
                                <tr>
                                    <td>Sensitivity</td>
                                    <td>>90-95%</td>
                                </tr>
                                <tr>
                                    <td>Specificity</td>
                                    <td>>99%</td>
                                </tr>
                                <tr>
                                    <td>Detection limit</td>
                                    <td>1-10 organisms</td>
                                </tr>
                                <tr>
                                    <td>FDA-approved sites</td>
                                    <td>Multiple</td>
                                </tr>
                            </table>
                        </div>
                        <div class="key-point">
                            <strong>Key Point:</strong>
                            <p>NAAT is the only recommended method for routine chlamydia diagnosis</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 23: Chlamydia Specimen Selection -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 23 of 45</div>
                <h2>Chlamydia: Specimen Selection</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Optimal Specimens by Scenario</h3>
                    <table class="small">
                        <thead>
                            <tr>
                                <th>Scenario</th>
                                <th>Preferred</th>
                                <th>Alternative</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Asymptomatic female</td>
                                <td>Vaginal swab (self)</td>
                                <td>First-void urine</td>
                            </tr>
                            <tr>
                                <td>Symptomatic female</td>
                                <td>Cervical swab</td>
                                <td>Vaginal swab</td>
                            </tr>
                            <tr>
                                <td>Male (any)</td>
                                <td>First-void urine</td>
                                <td>Urethral swab</td>
                            </tr>
                            <tr>
                                <td>Extragenital</td>
                                <td>Site-specific swab</td>
                                <td>-</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Self-Collection Advantages</h3>
                            <ul>
                                <li>Equal or better sensitivity than clinician-collected</li>
                                <li>Improved patient acceptability</li>
                                <li>Reduces clinical time</li>
                                <li>Enables outreach testing</li>
                            </ul>
                        </div>
                        <div class="key-point">
                            <strong>Best Practice:</strong>
                            <p>Offer self-collected vaginal swabs as first-line specimen for female screening</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 24: Chlamydia Special Considerations -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 24 of 45</div>
                <h2>Chlamydia: Special Considerations</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>LGV (Lymphogranuloma Venereum)</h3>
                    <ul>
                        <li>Caused by C. trachomatis serovars L1, L2, L3</li>
                        <li>Requires genotyping - not available in routine labs</li>
                        <li>Clinical diagnosis + positive chlamydia NAAT</li>
                        <li>Consider in: proctitis, inguinal buboes, genital ulcers</li>
                        <li>Treatment differs from non-LGV chlamydia</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Test of Cure</h3>
                            <table class="small">
                                <tr>
                                    <th>Recommendation</th>
                                    <th>Rationale</th>
                                </tr>
                                <tr>
                                    <td>NOT routine</td>
                                    <td>Dead organism detection</td>
                                </tr>
                                <tr>
                                    <td>Wait ≥4 weeks</td>
                                    <td>Minimize false positives</td>
                                </tr>
                                <tr>
                                    <td>Indicated for:</td>
                                    <td>
                                        • Pregnant women<br>
                                        • Compliance concerns<br>
                                        • Persistent symptoms
                                    </td>
                                </tr>
                            </table>
                        </div>
                        <div class="warning">
                            <strong>Important:</strong>
                            <p>Retest all patients at 3 months to detect reinfection (not test of cure)</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 25: Trichomoniasis Overview -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 25 of 45</div>
                <h2>Trichomonas vaginalis</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Key Facts</h3>
                    <ul>
                        <li>Flagellated protozoan parasite</li>
                        <li>Most common non-viral STI globally</li>
                        <li>70-85% asymptomatic</li>
                        <li>Associated with:
                            <ul>
                                <li>Adverse pregnancy outcomes</li>
                                <li>Increased HIV transmission (2-3x)</li>
                                <li>PID risk</li>
                            </ul>
                        </li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Clinical Manifestations</h3>
                            <table class="small">
                                <tr>
                                    <th>Population</th>
                                    <th>Symptoms</th>
                                </tr>
                                <tr>
                                    <td>Women</td>
                                    <td>Frothy discharge, vulvar irritation</td>
                                </tr>
                                <tr>
                                    <td>Men</td>
                                    <td>Usually asymptomatic</td>
                                </tr>
                                <tr>
                                    <td>Complications</td>
                                    <td>Preterm birth, low birth weight</td>
                                </tr>
                            </table>
                        </div>
                        <div class="key-point">
                            <strong>Public Health Impact:</strong>
                            <p>Often overlooked but has significant morbidity and facilitates HIV transmission</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 26: Trichomoniasis Diagnosis -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 26 of 45</div>
                <h2>Trichomoniasis: Diagnostic Methods</h2>
            </div>
            <div class="content">
                <h3>Diagnostic Methods Comparison</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Method</th>
                            <th>Sensitivity</th>
                            <th>Advantages</th>
                            <th>Limitations</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Wet Mount</strong></td>
                            <td>44-68%</td>
                            <td>Rapid, inexpensive</td>
                            <td>Requires immediate exam</td>
                        </tr>
                        <tr>
                            <td><strong>Culture</strong></td>
                            <td>75-96%</td>
                            <td>Viable organisms</td>
                            <td>3-7 days, special media</td>
                        </tr>
                        <tr>
                            <td><strong>NAAT</strong></td>
                            <td>>95%</td>
                            <td>Highly sensitive</td>
                            <td>Cost, availability</td>
                        </tr>
                        <tr>
                            <td><strong>Rapid Antigen</strong></td>
                            <td>82-95%</td>
                            <td>Point-of-care</td>
                            <td>Moderate sensitivity</td>
                        </tr>
                    </tbody>
                </table>

                <div class="two-columns" style="margin-top: 20px;">
                    <div>
                        <h3>Wet Mount Technique</h3>
                        <ol class="compact">
                            <li>Mix vaginal discharge with saline</li>
                            <li>Examine immediately (within 10 minutes)</li>
                            <li>Look for motile, flagellated organisms</li>
                            <li>Trichomonads are pear-shaped, 10-20 μm</li>
                        </ol>
                    </div>
                    <div class="warning">
                        <strong>Critical:</strong>
                        <p>Sensitivity decreases to 20% after 1 hour - immediate examination essential</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 27: Trichomoniasis Culture and NAAT -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 27 of 45</div>
                <h2>Trichomoniasis: Culture and NAAT</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Culture Methods</h3>
                    <ul>
                        <li><strong>InPouch TV:</strong> Self-contained system, read daily for 5 days</li>
                        <li><strong>Diamond's medium:</strong> Traditional culture method</li>
                        <li>Incubate at 37°C</li>
                        <li>More sensitive than wet mount</li>
                        <li>Allows for susceptibility testing if needed</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>NAAT Advantages</h3>
                            <ul>
                                <li>Superior sensitivity (>95%)</li>
                                <li>Can test vaginal, endocervical, or urine specimens</li>
                                <li>Some assays FDA-approved for male urine</li>
                                <li>Stable specimens</li>
                                <li>Batching possible</li>
                            </ul>
                        </div>
                        <div>
                            <div class="key-point">
                                <strong>Recommendation:</strong>
                                <p>NAAT is preferred for all symptomatic women and high-risk populations when available</p>
                            </div>
                            
                            <h3 style="margin-top: 20px;">Testing in Men</h3>
                            <ul class="compact">
                                <li>Historically challenging</li>
                                <li>NAAT from urine now available</li>
                                <li>Consider testing male partners</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 28: HSV Overview -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 28 of 45</div>
                <h2>Herpes Simplex Virus</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Key Characteristics</h3>
                    <ul>
                        <li>Two types: HSV-1 and HSV-2</li>
                        <li>Both can cause genital and oral infections</li>
                        <li>Lifelong infection with recurrences</li>
                        <li>Can be transmitted during asymptomatic shedding</li>
                        <li>Clinical diagnosis often unreliable</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <h3>When to Test</h3>
                    <div class="two-columns">
                        <div style="background: #eff6ff; padding: 16px; border-radius: 8px;">
                            <h4 style="color: #1e40af;">Direct Detection (Lesions)</h4>
                            <ul class="compact">
                                <li>Active vesicles/ulcers</li>
                                <li>Atypical lesions</li>
                                <li>Confirm clinical diagnosis</li>
                                <li>Type-specific identification</li>
                            </ul>
                        </div>
                        
                        <div style="background: #f0fdf4; padding: 16px; border-radius: 8px;">
                            <h4 style="color: #166534;">Serology (No Lesions)</h4>
                            <ul class="compact">
                                <li>Recurrent symptoms</li>
                                <li>Partner with HSV</li>
                                <li>HIV-positive patients</li>
                                <li>NOT for screening</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 29: HSV Direct Detection -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 29 of 45</div>
                <h2>HSV: Direct Detection Methods</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Specimen Collection</h3>
                    <ol>
                        <li>Unroof vesicle with needle/scalpel</li>
                        <li>Absorb vesicle fluid with swab</li>
                        <li>Vigorously swab base of ulcer</li>
                        <li>Place in viral transport medium</li>
                    </ol>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Detection Methods</h3>
                            <table class="small">
                                <thead>
                                    <tr>
                                        <th>Method</th>
                                        <th>Sensitivity</th>
                                        <th>Advantages</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>PCR</strong></td>
                                        <td>>95%</td>
                                        <td>HSV-1 vs HSV-2</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Culture</strong></td>
                                        <td>50-70%</td>
                                        <td>100% specific</td>
                                    </tr>
                                    <tr>
                                        <td><strong>DFA</strong></td>
                                        <td>60-70%</td>
                                        <td>Rapid results</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <div class="warning">
                            <strong>Timing Matters:</strong>
                            <p>Sensitivity decreases as lesions heal - test vesicles and early ulcers for best results</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 30: HSV Serological Testing -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 30 of 45</div>
                <h2>HSV: Serological Testing</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Type-Specific Serology</h3>
                    <ul>
                        <li>Detects IgG antibodies to HSV-1 and HSV-2</li>
                        <li>Based on glycoprotein G (gG-1 and gG-2)</li>
                        <li>Takes 12 weeks to develop antibodies</li>
                        <li>Cannot determine infection site</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Available Tests</h3>
                            <table class="small">
                                <tr>
                                    <th>Test Type</th>
                                    <th>Performance</th>
                                    <th>Comments</th>
                                </tr>
                                <tr>
                                    <td>HerpeSelect EIA</td>
                                    <td>Sens: 96-100%<br>Spec: 96-100%</td>
                                    <td>Laboratory-based</td>
                                </tr>
                                <tr>
                                    <td>Western Blot</td>
                                    <td>Gold standard</td>
                                    <td>Research only</td>
                                </tr>
                                <tr>
                                    <td>Point-of-care</td>
                                    <td>Variable</td>
                                    <td>Not recommended</td>
                                </tr>
                            </table>
                        </div>
                        <div class="key-point">
                            <strong>Caution:</strong>
                            <p>Positive serology does not indicate active infection or infectivity</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 31: HPV Overview -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 31 of 45</div>
                <h2>Human Papillomavirus (HPV)</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Key Facts</h3>
                    <ul>
                        <li>>150 HPV types, ~40 affect genital area</li>
                        <li>High-risk types: 16, 18 cause 70% of cervical cancers</li>
                        <li>Low-risk types: 6, 11 cause 90% of genital warts</li>
                        <li>Most infections clear spontaneously within 2 years</li>
                        <li>Persistent HR-HPV → cancer risk</li>
                    </ul>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>HPV Testing Indications</h3>
                            <table class="small">
                                <tr>
                                    <th style="background: #dcfce7;">Recommended</th>
                                    <th style="background: #fee2e2;">NOT Recommended</th>
                                </tr>
                                <tr>
                                    <td>
                                        • Cervical cancer screening<br>
                                        • ASC-US triage<br>
                                        • Post-treatment monitoring<br>
                                        • Primary screening >30 years
                                    </td>
                                    <td>
                                        • Men (any site)<br>
                                        • Genital wart diagnosis<br>
                                        • Routine STI screening<br>
                                        • Women <30 years (alone)
                                    </td>
                                </tr>
                            </table>
                        </div>
                        <div class="key-point">
                            <strong>Key Point:</strong>
                            <p>HPV testing is for cervical cancer prevention, not STI diagnosis</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 32: HPV Testing Methods -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 32 of 45</div>
                <h2>HPV: Testing Technologies</h2>
            </div>
            <div class="content">
                <h3>Available HPV Tests</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Test</th>
                            <th>Technology</th>
                            <th>Features</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Hybrid Capture 2</strong></td>
                            <td>DNA probe</td>
                            <td>• Detects 13 HR types<br>• Semi-quantitative</td>
                        </tr>
                        <tr>
                            <td><strong>Cobas HPV</strong></td>
                            <td>PCR</td>
                            <td>• Types 16, 18 + 12 others<br>• FDA primary screening</td>
                        </tr>
                        <tr>
                            <td><strong>Aptima HPV</strong></td>
                            <td>mRNA</td>
                            <td>• 14 HR types<br>• Higher specificity</td>
                        </tr>
                        <tr>
                            <td><strong>GeneXpert HPV</strong></td>
                            <td>PCR</td>
                            <td>• 14 HR types<br>• Point-of-care option</td>
                        </tr>
                    </tbody>
                </table>

                <h3 style="margin-top: 20px;">Screening Algorithms</h3>
                <table class="small">
                    <tr>
                        <th>Age Group</th>
                        <th>Recommended Screening</th>
                    </tr>
                    <tr>
                        <td>21-29 years</td>
                        <td>Cytology alone every 3 years</td>
                    </tr>
                    <tr>
                        <td>30-65 years</td>
                        <td>Co-testing every 5 years OR Cytology every 3 years</td>
                    </tr>
                    <tr>
                        <td>>65 years</td>
                        <td>Stop if adequate prior screening</td>
                    </tr>
                </table>
            </div>
        </div>

        <!-- Slide 33: Other STI Pathogens -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 33 of 45</div>
                <h2>Other STI Pathogens</h2>
            </div>
            <div class="content">
                <div class="three-columns compact">
                    <div>
                        <h3>Mycoplasma genitalium</h3>
                        <ul>
                            <li>Causes 15-20% of NGU in men</li>
                            <li>Associated with PID in women</li>
                            <li>High rates of antibiotic resistance</li>
                            <li><strong>Testing:</strong> NAAT only</li>
                            <li><strong>Important:</strong> Macrolide resistance >50%</li>
                        </ul>
                    </div>
                    <div>
                        <h3>Bacterial Vaginosis</h3>
                        <ul>
                            <li>Polymicrobial dysbiosis</li>
                            <li><strong>Amsel Criteria (3 of 4):</strong>
                                <ul>
                                    <li>Thin discharge</li>
                                    <li>pH >4.5</li>
                                    <li>Positive whiff test</li>
                                    <li>Clue cells >20%</li>
                                </ul>
                            </li>
                            <li><strong>Nugent Score:</strong> 7-10 = BV</li>
                        </ul>
                    </div>
                    <div>
                        <h3>Chancroid (H. ducreyi)</h3>
                        <ul>
                            <li>Rare in developed countries</li>
                            <li>Culture: Special media, <80% sensitive</li>
                            <li>PCR available in research settings</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 34: Point-of-Care Testing -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 34 of 45</div>
                <h2>Point-of-Care STI Testing</h2>
            </div>
            <div class="content">
                <h3>Available POC Tests</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Pathogen</th>
                            <th>Test Types</th>
                            <th>Time to Result</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>HIV</strong></td>
                            <td>• Rapid antibody<br>• 4th gen Ag/Ab</td>
                            <td>15-20 minutes</td>
                        </tr>
                        <tr>
                            <td><strong>Syphilis</strong></td>
                            <td>• Treponemal<br>• Dual HIV/syphilis</td>
                            <td>15-20 minutes</td>
                        </tr>
                        <tr>
                            <td><strong>Trichomonas</strong></td>
                            <td>• Antigen detection<br>• OSOM Trichomonas</td>
                            <td>10 minutes</td>
                        </tr>
                        <tr>
                            <td><strong>CT/NG</strong></td>
                            <td>• GeneXpert<br>• BioFire</td>
                            <td>60-90 minutes</td>
                        </tr>
                    </tbody>
                </table>

                <h3 style="margin-top: 20px;">Advantages vs Limitations</h3>
                <div class="two-columns">
                    <div style="background: #dcfce7; padding: 15px; border-radius: 8px;">
                        <h4>Advantages</h4>
                        <ul class="compact">
                            <li>Immediate results</li>
                            <li>Same-visit treatment</li>
                            <li>Improved patient flow</li>
                            <li>Outreach settings</li>
                        </ul>
                    </div>
                    <div style="background: #fee2e2; padding: 15px; border-radius: 8px;">
                        <h4>Limitations</h4>
                        <ul class="compact">
                            <li>Lower sensitivity</li>
                            <li>Limited test menu</li>
                            <li>Quality control issues</li>
                            <li>Higher cost per test</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 35: Multiplex Testing -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 35 of 45</div>
                <h2>Multiplex PCR Panels</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Available Multiplex Panels</h3>
                    <table class="small">
                        <thead>
                            <tr>
                                <th>Panel</th>
                                <th>Pathogens</th>
                                <th>Specimen</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>CT/NG</strong></td>
                                <td>C. trachomatis, N. gonorrhoeae</td>
                                <td>Multiple sites</td>
                            </tr>
                            <tr>
                                <td><strong>Vaginal</strong></td>
                                <td>BV, Candida, Trichomonas</td>
                                <td>Vaginal swab</td>
                            </tr>
                            <tr>
                                <td><strong>Extended STI</strong></td>
                                <td>CT, NG, TV, MG, HSV, TP</td>
                                <td>Genital, urine</td>
                            </tr>
                            <tr>
                                <td><strong>Ulcer</strong></td>
                                <td>HSV-1/2, T. pallidum, H. ducreyi</td>
                                <td>Lesion swab</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Benefits of Multiplex Testing</h3>
                            <ul>
                                <li>Comprehensive testing from single specimen</li>
                                <li>Detects co-infections (common)</li>
                                <li>Efficient laboratory workflow</li>
                                <li>Syndrome-based approach</li>
                                <li>Cost-effective for high-volume labs</li>
                            </ul>
                        </div>
                        <div class="key-point">
                            <strong>Consideration:</strong>
                            <p>Cost-effectiveness depends on local prevalence and testing volume</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 36: Future Technologies -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 36 of 45</div>
                <h2>Future Diagnostic Technologies</h2>
            </div>
            <div class="content">
                <h3>Emerging Technologies</h3>
                
                <div class="three-columns">
                    <div>
                        <h4>Digital PCR</h4>
                        <ul class="compact">
                            <li>Absolute quantification without standards</li>
                            <li>Higher precision for low copy numbers</li>
                            <li>Resistance mutation detection</li>
                        </ul>
                    </div>
                    <div>
                        <h4>Next-Generation Sequencing</h4>
                        <ul class="compact">
                            <li>Microbiome analysis</li>
                            <li>Unknown pathogen identification</li>
                            <li>Comprehensive resistance profiling</li>
                            <li>Outbreak investigation</li>
                        </ul>
                    </div>
                    <div>
                        <h4>AI/Machine Learning</h4>
                        <ul class="compact">
                            <li>Automated result interpretation</li>
                            <li>Risk prediction algorithms</li>
                            <li>Quality improvement</li>
                        </ul>
                    </div>
                </div>

                <h3 style="margin-top: 30px;">Self-Collection Advances</h3>
                <ul>
                    <li>Home testing kits with app integration</li>
                    <li>Dried blood spots for serology</li>
                    <li>Mailed specimens with tracking</li>
                </ul>
            </div>
        </div>

        <!-- Slide 37: Saudi National Guidelines -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 37 of 45</div>
                <h2>Saudi National Screening Guidelines</h2>
            </div>
            <div class="content">
                <h3>Recommended Screening Protocols</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Population</th>
                            <th>Tests Recommended</th>
                            <th>Frequency</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>Pregnant women</td>
                            <td>Syphilis, HIV, HBV</td>
                            <td>First visit + 3rd trimester</td>
                        </tr>
                        <tr>
                            <td>High-risk adults</td>
                            <td>HIV, Syphilis, CT/NG</td>
                            <td>Annual or more frequent</td>
                        </tr>
                        <tr>
                            <td>STI clinic attendees</td>
                            <td>Comprehensive panel</td>
                            <td>At presentation</td>
                        </tr>
                        <tr>
                            <td>Pre-marital</td>
                            <td>Per national program</td>
                            <td>Once</td>
                        </tr>
                    </tbody>
                </table>

                <div class="two-columns" style="margin-top: 20px;">
                    <div>
                        <h3>Laboratory Network</h3>
                        <ul class="compact">
                            <li>Reference laboratories for confirmatory testing</li>
                            <li>Regional labs for routine screening</li>
                            <li>Point-of-care in remote areas</li>
                            <li>Quality assurance program mandatory</li>
                        </ul>
                    </div>
                    <div class="key-point">
                        <strong>Integration:</strong>
                        <p>Laboratory results linked to HESN surveillance system for real-time monitoring</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 38: Case Study 1 -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 38 of 45</div>
                <h2>Case Study 1: Syphilis Diagnosis</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Clinical Scenario</h3>
                    <ul>
                        <li><strong>Patient:</strong> 28-year-old male</li>
                        <li><strong>Presentation:</strong> Painless genital ulcer for 1 week</li>
                        <li><strong>History:</strong> New sexual partner 3 weeks ago</li>
                    </ul>

                    <h3 style="margin-top: 20px;">Laboratory Approach</h3>
                    <ol>
                        <li>Direct detection: Swab ulcer for darkfield or PCR</li>
                        <li>Serology: RPR and TPPA</li>
                        <li>Additional: HIV, HSV PCR (rule out)</li>
                    </ol>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Results</h3>
                            <table class="small">
                                <tr>
                                    <th>Test</th>
                                    <th>Result</th>
                                </tr>
                                <tr>
                                    <td>Darkfield microscopy</td>
                                    <td>Positive for spirochetes</td>
                                </tr>
                                <tr>
                                    <td>RPR</td>
                                    <td>Reactive 1:32</td>
                                </tr>
                                <tr>
                                    <td>TPPA</td>
                                    <td>Positive</td>
                                </tr>
                                <tr>
                                    <td>HIV</td>
                                    <td>Negative</td>
                                </tr>
                            </table>
                        </div>
                        <div class="key-point">
                            <strong>Diagnosis:</strong> Primary syphilis<br>
                            <strong>Treatment:</strong> Benzathine penicillin G 2.4 MU IM<br>
                            <strong>Follow-up:</strong> RPR at 6 and 12 months
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 39: Case Study 2 -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 39 of 45</div>
                <h2>Case Study 2: Persistent Urethritis</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Clinical Scenario</h3>
                    <ul>
                        <li><strong>Patient:</strong> 25-year-old male</li>
                        <li><strong>Presentation:</strong> Persistent urethral discharge after treatment</li>
                        <li><strong>History:</strong> Treated for gonorrhea 3 weeks ago</li>
                    </ul>

                    <h3 style="margin-top: 20px;">Initial Testing</h3>
                    <ul>
                        <li>CT/NG NAAT: Both negative</li>
                        <li>Gram stain: WBCs, no organisms</li>
                    </ul>

                    <h3 style="margin-top: 20px;">Additional Testing</h3>
                    <ol class="compact">
                        <li><strong>M. genitalium NAAT</strong> - Common cause of persistent NGU</li>
                        <li><strong>T. vaginalis NAAT</strong> - Can cause urethritis in men</li>
                        <li><strong>HSV PCR</strong> - If any lesions</li>
                    </ol>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Results & Management</h3>
                            <ul>
                                <li><strong>M. genitalium:</strong> Positive</li>
                                <li><strong>Resistance testing:</strong> Macrolide resistant</li>
                                <li><strong>Treatment:</strong> Moxifloxacin 400mg daily × 7 days</li>
                                <li><strong>Partner notification:</strong> Essential</li>
                            </ul>
                        </div>
                        <div class="warning">
                            <strong>Key Learning:</strong>
                            <p>Consider M. genitalium in persistent NGU. Resistance is common - consider resistance-guided therapy.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 40: Case Study 3 -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 40 of 45</div>
                <h2>Case Study 3: Pregnancy Screening</h2>
            </div>
            <div class="content">
                <h3>Clinical Scenario</h3>
                <ul>
                    <li><strong>Patient:</strong> 22-year-old pregnant woman</li>
                    <li><strong>Presentation:</strong> First prenatal visit at 12 weeks</li>
                    <li><strong>History:</strong> No STI symptoms</li>
                </ul>

                <h3 style="margin-top: 20px;">Testing & Results</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Test</th>
                            <th>Result</th>
                            <th>Action</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>Syphilis (RPR)</td>
                            <td>Reactive 1:4</td>
                            <td>Confirm with TPPA</td>
                        </tr>
                        <tr>
                            <td>TPPA</td>
                            <td>Positive</td>
                            <td>Stage & treat urgently</td>
                        </tr>
                        <tr>
                            <td>HIV</td>
                            <td>Negative</td>
                            <td>Repeat 3rd trimester</td>
                        </tr>
                        <tr>
                            <td>HBsAg</td>
                            <td>Negative</td>
                            <td>Routine follow-up</td>
                        </tr>
                        <tr>
                            <td>CT/NG</td>
                            <td>CT positive</td>
                            <td>Treat & test of cure</td>
                        </tr>
                    </tbody>
                </table>

                <div class="warning" style="margin-top: 20px;">
                    <strong>Critical:</strong>
                    <p>Untreated syphilis in pregnancy → 40% risk of congenital syphilis. Immediate treatment essential!</p>
                </div>
            </div>
        </div>

        <!-- Slide 41: Laboratory Troubleshooting -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 41 of 45</div>
                <h2>Laboratory Troubleshooting</h2>
            </div>
            <div class="content">
                <h3>Common Issues and Solutions</h3>
                <table>
                    <thead>
                        <tr>
                            <th>Problem</th>
                            <th>Possible Causes</th>
                            <th>Solutions</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>NAAT inhibition</td>
                            <td>Blood, mucus, preservatives</td>
                            <td>Dilute specimen, use different platform</td>
                        </tr>
                        <tr>
                            <td>Culture contamination</td>
                            <td>Poor technique, transport delay</td>
                            <td>Training, selective media, rapid transport</td>
                        </tr>
                        <tr>
                            <td>Discordant serology</td>
                            <td>Early infection, false positive</td>
                            <td>Repeat testing, alternative methods</td>
                        </tr>
                        <tr>
                            <td>Invalid controls</td>
                            <td>Storage, expiration, technique</td>
                            <td>Check storage, new lot, retrain staff</td>
                        </tr>
                    </tbody>
                </table>

                <div class="two-columns" style="margin-top: 20px;">
                    <div>
                        <h3>When to Reject Specimens</h3>
                        <ul class="compact">
                            <li>Unlabeled or mislabeled</li>
                            <li>Wrong transport medium</li>
                            <li>Excessive transport time</li>
                            <li>Visible contamination</li>
                            <li>Insufficient quantity</li>
                        </ul>
                    </div>
                    <div class="key-point">
                        <strong>Best Practice:</strong>
                        <p>Communicate with clinical team before rejecting irreplaceable specimens</p>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 42: Key Laboratory Messages -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 42 of 45</div>
                <h2>Key Laboratory Messages</h2>
            </div>
            <div class="content">
                <div class="left-content">
                    <h3>Critical Points to Remember</h3>
                    <ol style="font-size: 18px; line-height: 1.8;">
                        <li><strong>NAAT is preferred</strong> for CT, NG, TV, MG when available</li>
                        <li><strong>Syphilis requires two tests</strong> - treponemal + non-treponemal</li>
                        <li><strong>Culture is essential</strong> for antimicrobial resistance monitoring</li>
                        <li><strong>Specimen quality</strong> determines test performance</li>
                        <li><strong>Extragenital testing</strong> based on sexual practices</li>
                    </ol>
                </div>
                
                <div class="full-width-content">
                    <div class="two-columns">
                        <div>
                            <h3>Common Pitfalls to Avoid</h3>
                            <ul>
                                <li>Using treponemal tests to monitor syphilis treatment</li>
                                <li>Testing too soon after exposure (window period)</li>
                                <li>Ignoring pre-analytical requirements</li>
                                <li>Not confirming positive screening tests</li>
                                <li>Poor communication with clinicians</li>
                            </ul>
                        </div>
                        <div class="key-point">
                            <strong>Excellence in STI testing requires continuous education and quality improvement</strong>
                        </div>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 43: Resources -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 43 of 45</div>
                <h2>Resources and References</h2>
            </div>
            <div class="content">
                <div class="three-columns">
                    <div>
                        <h3>Key Guidelines</h3>
                        <ul class="compact">
                            <li>Saudi MOH STI Treatment Guidelines 2024</li>
                            <li>WHO Laboratory Manual for STI Diagnosis</li>
                            <li>CDC STI Treatment Guidelines 2021</li>
                            <li>BASHH UK Testing Guidelines</li>
                            <li>IUSTI Global Guidelines</li>
                        </ul>
                    </div>
                    <div>
                        <h3>Professional Organizations</h3>
                        <ul class="compact">
                            <li>Saudi Society for Clinical Microbiology</li>
                            <li>International Union against STIs (IUSTI)</li>
                            <li>American Society for Microbiology (ASM)</li>
                            <li>Clinical and Laboratory Standards Institute (CLSI)</li>
                        </ul>
                    </div>
                    <div>
                        <h3>Continuing Education</h3>
                        <ul class="compact">
                            <li>Annual Saudi STI symposium</li>
                            <li>WHO online training modules</li>
                            <li>International proficiency programs</li>
                            <li>Manufacturer training programs</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <!-- Slide 44: Summary -->
        <div class="slide">
            <div class="slide-header-box">
                <div class="slide-number">Slide 44 of 45</div>
                <h2>Summary</h2>
            </div>
            <div class="content">
                <h3>Key Takeaways</h3>
                <ol style="font-size: 18px; line-height: 1.8;">
                    <li>Accurate laboratory diagnosis guides appropriate treatment</li>
                    <li>Different pathogens require different diagnostic approaches</li>
                    <li>Quality is essential at every step - pre-analytical to post-analytical</li>
                    <li>NAAT has revolutionized STI testing</li>
                    <li>Antimicrobial resistance surveillance is increasingly important</li>
                    <li>Integration with public health surveillance is essential</li>
                </ol>

                <h3 style="margin-top: 30px;">Call to Action</h3>
                <ul style="font-size: 18px; line-height: 1.8;">
                    <li>Implement best practices in your laboratory</li>
                    <li>Participate in quality assurance programs</li>
                    <li>Collaborate with clinical teams</li>
                    <li>Support surveillance efforts</li>
                    <li>Continue professional development</li>
                </ul>

                <div class="key-point" style="margin-top: 30px;">
                    <strong>Together, we can achieve STI control through laboratory excellence</strong>
                </div>
            </div>
        </div>

        <!-- Slide 45: Thank You -->
        <div class="slide">
            <div class="title-content">
                <h1 style="color: #1e293b; margin-bottom: 40px;">Thank You</h1>
                <p style="font-size: 24px; color: #64748b; margin-bottom: 40px;">Questions & Discussion</p>
                
                <div style="background: #f8fafc; padding: 40px; border-radius: 12px; max-width: 600px;">
                    <h3 style="color: #3b82f6; margin-bottom: 20px;">Contact Information</h3>
                    <p style="font-size: 18px; line-height: 1.8;">
                        <strong>STI Control Program</strong><br>
                        Ministry of Health - Saudi Arabia<br>
                        Email: sti.program@moh.gov.sa<br>
                        Website: www.moh.gov.sa/sti
                    </p>
                </div>
                
                <p style="font-size: 16px; color: #94a3b8; margin-top: 40px;">
                    © 2024 Ministry of Health, Saudi Arabia. All rights reserved.
                </p>
            </div>
        </div>

        <!-- Navigation -->
        <div class="navigation">
            <button class="nav-button" id="prevBtn" onclick="changeSlide(-1)">Previous</button>
            <span class="slide-counter">
                <span id="currentSlide">1</span> / <span id="totalSlides">45</span>
            </span>
            <button class="nav-button" id="nextBtn" onclick="changeSlide(1)">Next</button>
        </div>
    </div>

    <script>
        let currentSlide = 1;
        const slides = document.querySelectorAll('.slide');
        const totalSlides = slides.length;

        // Update total slides counter
        document.getElementById('totalSlides').textContent = totalSlides;

        function showSlide(n) {
            // Remove loading screen
            const loading = document.getElementById('loading');
            if (loading) {
                loading.style.display = 'none';
            }

            // Wrap around
            if (n > totalSlides) currentSlide = 1;
            if (n < 1) currentSlide = totalSlides;

            // Hide all slides
            slides.forEach(slide => {
                slide.classList.remove('active');
            });

            // Show current slide
            slides[currentSlide - 1].classList.add('active');

            // Update counter
            document.getElementById('currentSlide').textContent = currentSlide;

            // Update button states
            document.getElementById('prevBtn').disabled = currentSlide === 1;
            document.getElementById('nextBtn').disabled = currentSlide === totalSlides;

            // Update URL hash
            window.location.hash = `slide${currentSlide}`;
        }

        function changeSlide(n) {
            currentSlide += n;
            showSlide(currentSlide);
        }

        // Keyboard navigation
        document.addEventListener('keydown', (e) => {
            if (e.key === 'ArrowLeft') changeSlide(-1);
            if (e.key === 'ArrowRight') changeSlide(1);
            if (e.key === 'Home') { currentSlide = 1; showSlide(1); }
            if (e.key === 'End') { currentSlide = totalSlides; showSlide(totalSlides); }
        });

        // Touch/swipe support
        let touchStartX = 0;
        let touchEndX = 0;

        document.addEventListener('touchstart', (e) => {
            touchStartX = e.changedTouches[0].screenX;
        });

        document.addEventListener('touchend', (e) => {
            touchEndX = e.changedTouches[0].screenX;
            handleSwipe();
        });

        function handleSwipe() {
            if (touchEndX < touchStartX - 50) changeSlide(1);  // Swipe left
            if (touchEndX > touchStartX + 50) changeSlide(-1); // Swipe right
        }

        // Load slide from URL hash
        window.addEventListener('load', () => {
            const hash = window.location.hash;
            if (hash) {
                const slideNum = parseInt(hash.replace('#slide', ''));
                if (!isNaN(slideNum) && slideNum >= 1 && slideNum <= totalSlides) {
                    currentSlide = slideNum;
                }
            }
            showSlide(currentSlide);
        });

        // Handle hash changes
        window.addEventListener('hashchange', () => {
            const hash = window.location.hash;
            if (hash) {
                const slideNum = parseInt(hash.replace('#slide', ''));
                if (!isNaN(slideNum) && slideNum >= 1 && slideNum <= totalSlides) {
                    currentSlide = slideNum;
                    showSlide(currentSlide);
                }
            }
        });

        // Print support
        window.addEventListener('beforeprint', () => {
            slides.forEach(slide => {
                slide.classList.add('active');
            });
        });

        window.addEventListener('afterprint', () => {
            slides.forEach((slide, index) => {
                if (index !== currentSlide - 1) {
                    slide.classList.remove('active');
                }
            });
        });
    </script>
</body>
</html>
